0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccine Market Research Report 2021
Published Date: February 2021
|
Report Code: QYRE-Auto-31I4138
Home | Category |Health |Health Conditions |Infectious Diseases
Global Meningococcal Vaccine Market Research Report 2021

Global Meningococcal Vaccine Market Research Report 2021

Code: QYRE-Auto-31I4138
Report
February 2021
115 Pages
QYResearch
Region: Global, North America, Germany, France, Canada, Europe, Italy, Japan, Saudi Arabia, Turkey, Middle East & Africa, India, Australia, South Korea, Malaysia, Thailand, Indonesia, Vietnam, Brazil, Taiwan, Argentina, Philippines,
Description
Table of Content
Tables & Figures
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Quadrivalent
    Bivalent
    Others
Segment by Application
    Pneumonia
    Meningitis
    Bacteremia
    Others (Arthritis, Conjunctivitis, Urethritis)
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Novartis
    GSK
    Merck
    CSL
    Baxter
    JN International Medical Corporation
    Serum Institute of India
    Bio-Med
    China National Biotec Group
    Hualan Bio
    Walvax
    Zhifei
1 Meningococcal Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Vaccine
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Quadrivalent
1.2.3 Bivalent
1.2.4 Others
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Meningococcal Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Global Meningococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccine Revenue 2016-2027
1.4.2 Global Meningococcal Vaccine Sales 2016-2027
1.4.3 Meningococcal Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Meningococcal Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Meningococcal Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Meningococcal Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Vaccine Market Competitive Situation and Trends
2.5.1 Meningococcal Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Vaccine Players Market Share by Revenue
2.5.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningococcal Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Meningococcal Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Meningococcal Vaccine Market Facts & Figures by Country
3.3.1 North America Meningococcal Vaccine Sales by Country
3.3.2 North America Meningococcal Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meningococcal Vaccine Market Facts & Figures by Country
3.4.1 Europe Meningococcal Vaccine Sales by Country
3.4.2 Europe Meningococcal Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Meningococcal Vaccine Sales by Region
3.5.2 Asia Pacific Meningococcal Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meningococcal Vaccine Market Facts & Figures by Country
3.6.1 Latin America Meningococcal Vaccine Sales by Country
3.6.2 Latin America Meningococcal Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Meningococcal Vaccine Sales by Country
3.7.2 Middle East and Africa Meningococcal Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Meningococcal Vaccine Historic Market Analysis by Type
4.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Meningococcal Vaccine Price by Type (2016-2021)
5 Global Meningococcal Vaccine Historic Market Analysis by Application
5.1 Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Meningococcal Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL
6.4.1 CSL Corporation Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CSL Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Baxter Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 JN International Medical Corporation
6.6.1 JN International Medical Corporation Corporation Information
6.6.2 JN International Medical Corporation Description and Business Overview
6.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 JN International Medical Corporation Product Portfolio
6.6.5 JN International Medical Corporation Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Serum Institute of India Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bio-Med Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 China National Biotec Group
6.9.1 China National Biotec Group Corporation Information
6.9.2 China National Biotec Group Description and Business Overview
6.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China National Biotec Group Product Portfolio
6.9.5 China National Biotec Group Recent Developments/Updates
6.10 Hualan Bio
6.10.1 Hualan Bio Corporation Information
6.10.2 Hualan Bio Description and Business Overview
6.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Hualan Bio Product Portfolio
6.10.5 Hualan Bio Recent Developments/Updates
6.11 Walvax
6.11.1 Walvax Corporation Information
6.11.2 Walvax Meningococcal Vaccine Description and Business Overview
6.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Walvax Product Portfolio
6.11.5 Walvax Recent Developments/Updates
6.12 Zhifei
6.12.1 Zhifei Corporation Information
6.12.2 Zhifei Meningococcal Vaccine Description and Business Overview
6.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Zhifei Product Portfolio
6.12.5 Zhifei Recent Developments/Updates
7 Meningococcal Vaccine Manufacturing Cost Analysis
7.1 Meningococcal Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Vaccine
7.4 Meningococcal Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meningococcal Vaccine Distributors List
8.3 Meningococcal Vaccine Customers
9 Meningococcal Vaccine Market Dynamics
9.1 Meningococcal Vaccine Industry Trends
9.2 Meningococcal Vaccine Growth Drivers
9.3 Meningococcal Vaccine Market Challenges
9.4 Meningococcal Vaccine Market Restraints
10 Global Market Forecast
10.1 Meningococcal Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Meningococcal Vaccine by Type (2022-2027)
10.2 Meningococcal Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meningococcal Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Meningococcal Vaccine by Application (2022-2027)
10.3 Meningococcal Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meningococcal Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Meningococcal Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Meningococcal Vaccine Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Meningococcal Vaccine Sales (K Dose) Comparison by Application (2021-2027)
    Table 3. Global Meningococcal Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Meningococcal Vaccine Covered in This Study
    Table 5. Global Meningococcal Vaccine Sales (K Dose) of Key Manufacturers (2016-2021)
    Table 6. Global Meningococcal Vaccine Sales Share by Manufacturers (2016-2021)
    Table 7. Global Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Meningococcal Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Meningococcal Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Meningococcal Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Meningococcal Vaccine Product Type
    Table 12. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 16. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 19. North America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 23. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 27. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 31. Latin America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 35. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Meningococcal Vaccine Sales (K Dose) by Type (2016-2021)
    Table 39. Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Meningococcal Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Meningococcal Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Meningococcal Vaccine Price (USD/Dose) by Type (2016-2021)
    Table 43. Global Meningococcal Vaccine Sales (K Dose) by Application (2016-2021)
    Table 44. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Meningococcal Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Meningococcal Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Meningococcal Vaccine Price (USD/Dose) by Application (2016-2021)
    Table 48. Novartis Corporation Information
    Table 49. Novartis Description and Business Overview
    Table 50. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 51. Novartis Meningococcal Vaccine Product
    Table 52. Novartis Recent Developments/Updates
    Table 53. GSK Corporation Information
    Table 54. GSK Description and Business Overview
    Table 55. GSK Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 56. GSK Meningococcal Vaccine Product
    Table 57. GSK Recent Developments/Updates
    Table 58. Merck Corporation Information
    Table 59. Merck Description and Business Overview
    Table 60. Merck Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 61. Merck Meningococcal Vaccine Product
    Table 62. Merck Recent Developments/Updates
    Table 63. CSL Corporation Information
    Table 64. CSL Description and Business Overview
    Table 65. CSL Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 66. CSL Meningococcal Vaccine Product
    Table 67. CSL Recent Developments/Updates
    Table 68. Baxter Corporation Information
    Table 69. Baxter Description and Business Overview
    Table 70. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 71. Baxter Meningococcal Vaccine Product
    Table 72. Baxter Recent Developments/Updates
    Table 73. JN International Medical Corporation Corporation Information
    Table 74. JN International Medical Corporation Description and Business Overview
    Table 75. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 76. JN International Medical Corporation Meningococcal Vaccine Product
    Table 77. JN International Medical Corporation Recent Developments/Updates
    Table 78. Serum Institute of India Corporation Information
    Table 79. Serum Institute of India Description and Business Overview
    Table 80. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 81. Serum Institute of India Meningococcal Vaccine Product
    Table 82. Serum Institute of India Recent Developments/Updates
    Table 83. Bio-Med Corporation Information
    Table 84. Bio-Med Description and Business Overview
    Table 85. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 86. Bio-Med Meningococcal Vaccine Product
    Table 87. Bio-Med Recent Developments/Updates
    Table 88. China National Biotec Group Corporation Information
    Table 89. China National Biotec Group Description and Business Overview
    Table 90. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 91. China National Biotec Group Meningococcal Vaccine Product
    Table 92. China National Biotec Group Recent Developments/Updates
    Table 93. Hualan Bio Corporation Information
    Table 94. Hualan Bio Description and Business Overview
    Table 95. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 96. Hualan Bio Meningococcal Vaccine Product
    Table 97. Hualan Bio Recent Developments/Updates
    Table 98. Walvax Corporation Information
    Table 99. Walvax Description and Business Overview
    Table 100. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 101. Walvax Meningococcal Vaccine Product
    Table 102. Walvax Recent Developments/Updates
    Table 103. Zhifei Corporation Information
    Table 104. Zhifei Description and Business Overview
    Table 105. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 106. Zhifei Meningococcal Vaccine Product
    Table 107. Zhifei Recent Developments/Updates
    Table 108. Production Base and Market Concentration Rate of Raw Material
    Table 109. Key Suppliers of Raw Materials
    Table 110. Meningococcal Vaccine Distributors List
    Table 111. Meningococcal Vaccine Customers List
    Table 112. Meningococcal Vaccine Market Trends
    Table 113. Meningococcal Vaccine Growth Drivers
    Table 114. Meningococcal Vaccine Market Restraints
    Table 115. Global Meningococcal Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
    Table 116. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 117. Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 118. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 119. Global Meningococcal Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
    Table 120. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 121. Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 122. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 123. Global Meningococcal Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
    Table 124. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 125. Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 126. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Meningococcal Vaccine
    Figure 2. Global Meningococcal Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Quadrivalent Product Picture
    Figure 4. Bivalent Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Meningococcal Vaccine Market Share by Application in 2020 & 2027
    Figure 7. Pneumonia
    Figure 8. Meningitis
    Figure 9. Bacteremia
    Figure 10. Others (Arthritis, Conjunctivitis, Urethritis)
    Figure 11. Global Meningococcal Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Meningococcal Vaccine Market Size 2016-2027 (US$ Million)
    Figure 13. Global Meningococcal Vaccine Sales 2016-2027 (K Dose)
    Figure 14. Global Meningococcal Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 15. Meningococcal Vaccine Sales Share by Manufacturers in 2020
    Figure 16. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2020
    Figure 17. The Global 5 and 10 Largest Meningococcal Vaccine Players: Market Share by Revenue in 2020
    Figure 18. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 19. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Figure 20. Global Meningococcal Vaccine Sales Market Share by Region in 2020
    Figure 21. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
    Figure 22. Global Meningococcal Vaccine Revenue Market Share by Region in 2020
    Figure 23. U.S. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Canada Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Germany Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. France Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. U.K. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Italy Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Russia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. China Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Japan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. South Korea Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. India Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Australia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Taiwan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Indonesia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Thailand Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Malaysia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Philippines Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Vietnam Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Mexico Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Brazil Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Argentina Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Turkey Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. U.A.E Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Sales Market Share of Meningococcal Vaccine by Type (2016-2021)
    Figure 48. Sales Market Share of Meningococcal Vaccine by Application (2016-2021)
    Figure 49. Sales Market Share of Meningococcal Vaccine by Application in 2020
    Figure 50. Revenue Share of Meningococcal Vaccine by Application (2016-2021)
    Figure 51. Revenue Share of Meningococcal Vaccine by Application in 2020
    Figure 52. Manufacturing Cost Structure of Meningococcal Vaccine
    Figure 53. Manufacturing Process Analysis of Meningococcal Vaccine
    Figure 54. Meningococcal Vaccine Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Quadrivalent
    Bivalent
    Others
Segment by Application
    Pneumonia
    Meningitis
    Bacteremia
    Others (Arthritis, Conjunctivitis, Urethritis)
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Novartis
    GSK
    Merck
    CSL
    Baxter
    JN International Medical Corporation
    Serum Institute of India
    Bio-Med
    China National Biotec Group
    Hualan Bio
    Walvax
    Zhifei
Read More
1 Meningococcal Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Vaccine
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Quadrivalent
1.2.3 Bivalent
1.2.4 Others
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Meningococcal Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Global Meningococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccine Revenue 2016-2027
1.4.2 Global Meningococcal Vaccine Sales 2016-2027
1.4.3 Meningococcal Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Meningococcal Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Meningococcal Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Meningococcal Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Vaccine Market Competitive Situation and Trends
2.5.1 Meningococcal Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Vaccine Players Market Share by Revenue
2.5.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningococcal Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Meningococcal Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Meningococcal Vaccine Market Facts & Figures by Country
3.3.1 North America Meningococcal Vaccine Sales by Country
3.3.2 North America Meningococcal Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meningococcal Vaccine Market Facts & Figures by Country
3.4.1 Europe Meningococcal Vaccine Sales by Country
3.4.2 Europe Meningococcal Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Meningococcal Vaccine Sales by Region
3.5.2 Asia Pacific Meningococcal Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meningococcal Vaccine Market Facts & Figures by Country
3.6.1 Latin America Meningococcal Vaccine Sales by Country
3.6.2 Latin America Meningococcal Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Meningococcal Vaccine Sales by Country
3.7.2 Middle East and Africa Meningococcal Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Meningococcal Vaccine Historic Market Analysis by Type
4.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Meningococcal Vaccine Price by Type (2016-2021)
5 Global Meningococcal Vaccine Historic Market Analysis by Application
5.1 Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Meningococcal Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL
6.4.1 CSL Corporation Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CSL Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Baxter Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 JN International Medical Corporation
6.6.1 JN International Medical Corporation Corporation Information
6.6.2 JN International Medical Corporation Description and Business Overview
6.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 JN International Medical Corporation Product Portfolio
6.6.5 JN International Medical Corporation Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Serum Institute of India Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bio-Med Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 China National Biotec Group
6.9.1 China National Biotec Group Corporation Information
6.9.2 China National Biotec Group Description and Business Overview
6.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China National Biotec Group Product Portfolio
6.9.5 China National Biotec Group Recent Developments/Updates
6.10 Hualan Bio
6.10.1 Hualan Bio Corporation Information
6.10.2 Hualan Bio Description and Business Overview
6.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Hualan Bio Product Portfolio
6.10.5 Hualan Bio Recent Developments/Updates
6.11 Walvax
6.11.1 Walvax Corporation Information
6.11.2 Walvax Meningococcal Vaccine Description and Business Overview
6.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Walvax Product Portfolio
6.11.5 Walvax Recent Developments/Updates
6.12 Zhifei
6.12.1 Zhifei Corporation Information
6.12.2 Zhifei Meningococcal Vaccine Description and Business Overview
6.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Zhifei Product Portfolio
6.12.5 Zhifei Recent Developments/Updates
7 Meningococcal Vaccine Manufacturing Cost Analysis
7.1 Meningococcal Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Vaccine
7.4 Meningococcal Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meningococcal Vaccine Distributors List
8.3 Meningococcal Vaccine Customers
9 Meningococcal Vaccine Market Dynamics
9.1 Meningococcal Vaccine Industry Trends
9.2 Meningococcal Vaccine Growth Drivers
9.3 Meningococcal Vaccine Market Challenges
9.4 Meningococcal Vaccine Market Restraints
10 Global Market Forecast
10.1 Meningococcal Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Meningococcal Vaccine by Type (2022-2027)
10.2 Meningococcal Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meningococcal Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Meningococcal Vaccine by Application (2022-2027)
10.3 Meningococcal Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meningococcal Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Meningococcal Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Read More
List of Tables
    Table 1. Global Meningococcal Vaccine Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Meningococcal Vaccine Sales (K Dose) Comparison by Application (2021-2027)
    Table 3. Global Meningococcal Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Meningococcal Vaccine Covered in This Study
    Table 5. Global Meningococcal Vaccine Sales (K Dose) of Key Manufacturers (2016-2021)
    Table 6. Global Meningococcal Vaccine Sales Share by Manufacturers (2016-2021)
    Table 7. Global Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Meningococcal Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Meningococcal Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Meningococcal Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Meningococcal Vaccine Product Type
    Table 12. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 16. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 19. North America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 23. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)
    Table 27. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 31. Latin America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)
    Table 35. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Meningococcal Vaccine Sales (K Dose) by Type (2016-2021)
    Table 39. Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Meningococcal Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Meningococcal Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Meningococcal Vaccine Price (USD/Dose) by Type (2016-2021)
    Table 43. Global Meningococcal Vaccine Sales (K Dose) by Application (2016-2021)
    Table 44. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Meningococcal Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Meningococcal Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Meningococcal Vaccine Price (USD/Dose) by Application (2016-2021)
    Table 48. Novartis Corporation Information
    Table 49. Novartis Description and Business Overview
    Table 50. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 51. Novartis Meningococcal Vaccine Product
    Table 52. Novartis Recent Developments/Updates
    Table 53. GSK Corporation Information
    Table 54. GSK Description and Business Overview
    Table 55. GSK Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 56. GSK Meningococcal Vaccine Product
    Table 57. GSK Recent Developments/Updates
    Table 58. Merck Corporation Information
    Table 59. Merck Description and Business Overview
    Table 60. Merck Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 61. Merck Meningococcal Vaccine Product
    Table 62. Merck Recent Developments/Updates
    Table 63. CSL Corporation Information
    Table 64. CSL Description and Business Overview
    Table 65. CSL Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 66. CSL Meningococcal Vaccine Product
    Table 67. CSL Recent Developments/Updates
    Table 68. Baxter Corporation Information
    Table 69. Baxter Description and Business Overview
    Table 70. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 71. Baxter Meningococcal Vaccine Product
    Table 72. Baxter Recent Developments/Updates
    Table 73. JN International Medical Corporation Corporation Information
    Table 74. JN International Medical Corporation Description and Business Overview
    Table 75. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 76. JN International Medical Corporation Meningococcal Vaccine Product
    Table 77. JN International Medical Corporation Recent Developments/Updates
    Table 78. Serum Institute of India Corporation Information
    Table 79. Serum Institute of India Description and Business Overview
    Table 80. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 81. Serum Institute of India Meningococcal Vaccine Product
    Table 82. Serum Institute of India Recent Developments/Updates
    Table 83. Bio-Med Corporation Information
    Table 84. Bio-Med Description and Business Overview
    Table 85. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 86. Bio-Med Meningococcal Vaccine Product
    Table 87. Bio-Med Recent Developments/Updates
    Table 88. China National Biotec Group Corporation Information
    Table 89. China National Biotec Group Description and Business Overview
    Table 90. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 91. China National Biotec Group Meningococcal Vaccine Product
    Table 92. China National Biotec Group Recent Developments/Updates
    Table 93. Hualan Bio Corporation Information
    Table 94. Hualan Bio Description and Business Overview
    Table 95. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 96. Hualan Bio Meningococcal Vaccine Product
    Table 97. Hualan Bio Recent Developments/Updates
    Table 98. Walvax Corporation Information
    Table 99. Walvax Description and Business Overview
    Table 100. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 101. Walvax Meningococcal Vaccine Product
    Table 102. Walvax Recent Developments/Updates
    Table 103. Zhifei Corporation Information
    Table 104. Zhifei Description and Business Overview
    Table 105. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 106. Zhifei Meningococcal Vaccine Product
    Table 107. Zhifei Recent Developments/Updates
    Table 108. Production Base and Market Concentration Rate of Raw Material
    Table 109. Key Suppliers of Raw Materials
    Table 110. Meningococcal Vaccine Distributors List
    Table 111. Meningococcal Vaccine Customers List
    Table 112. Meningococcal Vaccine Market Trends
    Table 113. Meningococcal Vaccine Growth Drivers
    Table 114. Meningococcal Vaccine Market Restraints
    Table 115. Global Meningococcal Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
    Table 116. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 117. Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 118. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 119. Global Meningococcal Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
    Table 120. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 121. Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 122. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 123. Global Meningococcal Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
    Table 124. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 125. Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 126. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Meningococcal Vaccine
    Figure 2. Global Meningococcal Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Quadrivalent Product Picture
    Figure 4. Bivalent Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Meningococcal Vaccine Market Share by Application in 2020 & 2027
    Figure 7. Pneumonia
    Figure 8. Meningitis
    Figure 9. Bacteremia
    Figure 10. Others (Arthritis, Conjunctivitis, Urethritis)
    Figure 11. Global Meningococcal Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Meningococcal Vaccine Market Size 2016-2027 (US$ Million)
    Figure 13. Global Meningococcal Vaccine Sales 2016-2027 (K Dose)
    Figure 14. Global Meningococcal Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 15. Meningococcal Vaccine Sales Share by Manufacturers in 2020
    Figure 16. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2020
    Figure 17. The Global 5 and 10 Largest Meningococcal Vaccine Players: Market Share by Revenue in 2020
    Figure 18. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 19. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
    Figure 20. Global Meningococcal Vaccine Sales Market Share by Region in 2020
    Figure 21. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
    Figure 22. Global Meningococcal Vaccine Revenue Market Share by Region in 2020
    Figure 23. U.S. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Canada Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Germany Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. France Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. U.K. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Italy Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Russia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. China Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Japan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. South Korea Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. India Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Australia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Taiwan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Indonesia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Thailand Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Malaysia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Philippines Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Vietnam Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Mexico Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Brazil Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Argentina Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Turkey Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. U.A.E Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Sales Market Share of Meningococcal Vaccine by Type (2016-2021)
    Figure 48. Sales Market Share of Meningococcal Vaccine by Application (2016-2021)
    Figure 49. Sales Market Share of Meningococcal Vaccine by Application in 2020
    Figure 50. Revenue Share of Meningococcal Vaccine by Application (2016-2021)
    Figure 51. Revenue Share of Meningococcal Vaccine by Application in 2020
    Figure 52. Manufacturing Cost Structure of Meningococcal Vaccine
    Figure 53. Manufacturing Process Analysis of Meningococcal Vaccine
    Figure 54. Meningococcal Vaccine Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Meningococcal Vaccine Market Research Report 2021
Global Meningococcal Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31I4138
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Latent tuberculosis Testing Market Size Status and Forecast 2021 2027
Global Latent tuberculosis Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-33Z4080
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Avian Influenza Vaccines Market Research Report 2021
Global Avian Influenza Vaccines Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-9K4476
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Polio Vaccine Market Research Report 2021
Global Polio Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-18B4237
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0